"No working capital" is exactly the problem. The working capital required is R & D, which they capitalised every year, when it should IMO be expensed. Back out R & D and the NPAT doesnt look quite that flash anymore.
- Forums
- ASX - By Stock
- GLH
- Ann: FY15 Half-Year Accounts and 4D
Ann: FY15 Half-Year Accounts and 4D, page-3
Featured News
Add GLH (ASX) to my watchlist
(20min delay)
|
|||||
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.126M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9063 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 13548 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9063 | 0.130 |
1 | 800 | 0.125 |
1 | 69000 | 0.110 |
1 | 61714 | 0.105 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 13548 | 1 |
0.155 | 30000 | 1 |
0.160 | 49240 | 2 |
0.165 | 71117 | 1 |
0.170 | 65251 | 2 |
Last trade - 16.12pm 15/11/2024 (20 minute delay) ? |
Featured News
GLH (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online